Lumeon raises £22.9m to support US growth

Lumeon, the digital care pathway solution, has closed $30M in Series D funding led by new investors.

The investment will be used to expand the care coordination platform into new markets, and follows a similar amount raised by the company in 2018.

Chelsea and Westminster Hospital NHS Foundation Trust is one of the company’s customer, who has utilised Lumeon’s Care Pathway Management platform to gain efficiencies in their busy postnatal maternity service and improve the experience for patients, their families and staff. Lumeon partnered with CW+, the charity of Chelsea and Westminster Hospital NHS FT who funded this project, to co-create, test and embed the digital end-to-end care pathway.

Lumeon Founder and CEO Robbie Hughes, said: While the markets for data analytics, clinical decision support and patient engagement are well established, what is missing today is the ability to effectively connect them to solve the problem of personalising care delivery in a scalable way.”

“The last mile that turns the insight into action is the hardest part for health systems, and is the core of the Lumeon proposition.

“This investment will allow us to continue on our rapid growth path, as we help healthcare systems develop and scale new models of delivery.”

Principal Dr. Ashish Patel from Optum Ventures, one of the new investors, said: “As the technology-driven transformation of healthcare is accelerated by COVID-19, Lumeon’s ability to optimise the care of every patient based on individual risk, cost, engagement and social determinants is crucial for their customers to operate effectively.